Raja et al. developed a protocol for the culture of organoids derived from AD patients’ iPSCs which recapitulated characteristic features of the pathology, i.e., hyperphosphorylated tau protein, amyloid aggregation, and endosome abnormalities (Raja et al., 2016). The gene discussed is MAPT; the disease is Alzheimer disease.